https://www.selleckchem.com/pr....oducts/bay-2666605.h
037 L (p = 0.16, 0.119 L (p less then 0.001), and 0.094 (p less then 0.001) for 50/6, 100/12, and 200/24, respectively. No safety signals were found.Conclusion CHF1535 was as effective as free combination BDP/FF, with a trend towards a dose-related response. All treatments were safe.Trial registration ClinicalTrials.gov ID NCT01584492 What is Known •Inhaled pressurized metered-dose solutions (pMDI) are the preferred treatment for pediatric asthma. •Combination therapy of inhaled corticosteroids and long-acting β2- agonists is a we
Me gusta
Comentario
Compartir
